Announcements Trials
Browse Landscape

Phase

Phase NA 94Phase 2 6Phase 3 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Pharyngeal Neoplasms 1Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Resistance Training × Clear all
NCT01332682 2023-10-18

Resistance Training and Physical Functioning in Head and Neck Cancer Patients

University of Alabama at Birmingham

Phase 1 Completed
18 enrolled
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Pharyngeal Neoplasms

NCT00798200 2016-03-03

CanWell

McMaster University

Phase 1 Completed
200 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡